Cleerly

Cleerly Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Cleerly, Medical and health, 110 16th Street, Suite 1400 #104, Denver, CO.

Cleerly is a comprehensive, AI-driven platform that quantifies and assesses coronary artery disease (CAD) to deliver clinically actionable insights through a web-based solution. Our software quantifies atherosclerosis by measuring plaque volume, composition, length, and location, evaluates stenosis severity in both 2D (diameter and area) and 3D (lumen and vessel volume), with a workflow for determining the likely presence or absence of ischemia, potentially reducing the need for additional testing and enhancing diagnostic confidence.

✨ Effective today, we're entering a new chapter in heart care coverage. Cleerly's AI-enabled plaque analysis is now bill...
01/01/2026

✨ Effective today, we're entering a new chapter in heart care coverage.

Cleerly's AI-enabled plaque analysis is now billable under Category I CPT® Code 75577.

Category I designation signals that quantitative plaque assessment is no longer considered experimental; it's a recognized tool that supports doctors in targeting the primary cause of heart disease: plaque buildup in the heart's arteries.

Cleerly helped lead this effort with the American Medical Association over the past five years, and we're excited about what this means for people seeking earlier, clearer answers about their heart health.

Here's to a brighter, healthier 2026! ❤️

From our hearts to yours, Happy Holidays from team Cleerly!Wishing you a season full of clarity, connection, and time to...
12/25/2025

From our hearts to yours, Happy Holidays from team Cleerly!

Wishing you a season full of clarity, connection, and time to focus on what matters most. ❤️

✨ A truly inspiring night at the 2025 Prix Galien USA Awards in New York City!We're proud Cleerly was named a finalist f...
11/06/2025

✨ A truly inspiring night at the 2025 Prix Galien USA Awards in New York City!

We're proud Cleerly was named a finalist for Best Digital Health Solution, and honored to be in great company with so many passionate innovators.

Big thanks to Galien Foundation for this recognition, and congratulations to this year's category winner, ŌURA.

We're so grateful for everyone who supports our mission at Cleerly! Your belief inspires us to keep pushing boundaries.

Looking forward to what's ahead! 🚀❤️

🎃 Precision meets personality. 👻Happy   from team Cleerly!
10/31/2025

🎃 Precision meets personality. 👻

Happy from team Cleerly!

09/29/2025

On 🌎❤️, we pause to recognize the millions of lives shaped by heart disease, not as statistics, but as stories, families, and futures.

At Cleerly, we believe in a world where heart attacks can be prevented, where doctors have the clarity to act earlier, and where communities thrive with better access to life-saving care.

This work is not easy, but it's necessary. And we are committed, alongside HCPs, researchers, and advocates worldwide, to creating a new standard of care. One that redefines what it means to protect the heart.

The path forward is bold. The purpose is profound. And our dedication will not waver.

✨ Wow, simply wow! We're truly honored to be named among TIME's World's Top HealthTech Companies of 2025.This recognitio...
09/19/2025

✨ Wow, simply wow! We're truly honored to be named among TIME's World's Top HealthTech Companies of 2025.

This recognition reflects the urgent need for innovation in cardiology. We're proud to be advancing cardiovascular care with AI, helping physicians make more informed, data-driven decisions for their patients.

👉 Learn more: https://bit.ly/46M2ive

If warning signs are absent in so many cases, how reliable is a symptom-driven approach to cardiovascular risk? 🤔For dec...
09/15/2025

If warning signs are absent in so many cases, how reliable is a symptom-driven approach to cardiovascular risk? 🤔

For decades, preventive strategies have used cholesterol and other indirect markers to guide clinical decision-making. Yet plaque can often accumulate silently, advancing until it triggers a major adverse cardiovascular event.

If the absence of symptoms does not equal the absence of disease, then it's critical that the disease itself, plaque, comes into clinical view. 🔍🫀

*Cleerly LABS is not a screening tool and should be used only for patients with CAD or suspected of CAD.

For over a century, heart disease has been the leading killer, yet non-invasive methods for evaluating it primarily rely...
09/08/2025

For over a century, heart disease has been the leading killer, yet non-invasive methods for evaluating it primarily rely on indirect markers instead of directly assessing the disease itself. 🤯💔

As a result, plaque buildup (atherosclerosis) in the arteries can progress silently until it causes a Major Adverse Cardiovascular Event (MACE).

At Cleerly, we're committed to changing this trajectory. Our AI-enabled CCTA solution enables physicians to quantify and characterize plaque, providing comprehensive, accurate, and trackable insights to personalize heart attack prevention.

Rest isn’t a pause from purpose, it’s part of it. 🚀❤️On  , we recognize those who dedicate themselves tirelessly to thei...
09/01/2025

Rest isn’t a pause from purpose, it’s part of it. 🚀❤️

On , we recognize those who dedicate themselves tirelessly to their responsibilities and the communities they serve. Taking a moment to slow down, recharge, and breathe is as important for our hearts as it is for our work.

Happy Labor Day from team Cleerly!

Some heart tests are built on assumptions.They assume steady blood flow.They assume your vessels are fully open.They est...
08/29/2025

Some heart tests are built on assumptions.

They assume steady blood flow.
They assume your vessels are fully open.
They estimate how your heart is working,
based on math, not what's actually happening.

At Cleerly, we use real-time data
to help doctors evaluate your arteries
and better understand your heart health.

Skip the hypotheticals.
See more of what matters.

Billing clarity 🤝 clinical clarity.Cleerly ISCHEMIA, our AI-enabled, CCTA-based approach for identifying the likelihood ...
08/27/2025

Billing clarity 🤝 clinical clarity.

Cleerly ISCHEMIA, our AI-enabled, CCTA-based approach for identifying the likelihood of vessel-level ischemia, is eligible for reimbursement under Category I CPT® Code 75580.

This code applies to noninvasive coronary FFR estimates derived from software-based analysis of CCTA data, interpreted by a physician or other qualified healthcare provider.

✅ Lesion-by-lesion mapping

✅ Supports intervention decisions

✅ Meets guidelines for CPT 75580

👉 Contact us to learn how Cleerly can support you clinically and operationally. Link in bio!

Precision Matters.Smaller vessels can hold critical insights...Yet other imaging tools only analyze vessels 1.8 mm and l...
08/21/2025

Precision Matters.
Smaller vessels can hold critical insights...

Yet other imaging tools only analyze vessels 1.8 mm and larger.
At Cleerly, we go deeper, evaluating vessels as small as 1.5 mm.

Smaller vessels. ✅ More insight. ✅

Address

110 16th Street, Suite 1400 #104
Denver, CO
80202

Website

https://cleerlyhealth.com/indications-for-use

Alerts

Be the first to know and let us send you an email when Cleerly posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Cleerly:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram